EUVIMEDEUVIMED entdecken
Crossref

Periaortic lymphatic vessels protect against thoracic aortic dissection through mobilizing immune response

Yujun Pei, Weirui Lin, Tao Zhang, Xiangyu Chu, Han Xu, Yizhe Sun, Min Xu, Yanjiani Xu iD, Fangyang Huang iD, Di Huang, Liang Shi, Hu Zhao und 7 weitere

Cardiovascular Research · 18.12.2025 · 121 (16) · 2594-2609

DOI: 10.1093/cvr/cvaf215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 10.11.2025. Verfasst von Yujun Pei und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Vascular Biology, Institute of Molecular Medicine, School of Future Technology, Beijing Key Laboratory of Cardiometabolic Molecular Med…. Hauptthemen laut MEDLINE: Lymphatic Vessels, Aortic Dissection, Aortic Aneurysm, Thoracic, Lymphangiogenesis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, National Key research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Inflammation and the immune response are crucial factors in the progression of thoracic aortic dissection (TAD), while lymphatic vessels (LVs) play a key role in regulating the inflammatory response by facilitating the drainage of inflammatory mediators, and immune cell trafficking. Here, we investigated the role of LVs in the pathogenesis of TAD. Methods and results Aortas collected from TAD patients and mice both showed a reduction in the number of periaortic LVs during TAD progression. Genetic linage tracing, tissue clearing technology, and fluorochrome tracers were used to explore the draining lymph nodes (LNs) of the aorta. The results demonstrated that the tracheobronchial lymph node (TLN) was the primary draining LN for the thoracic aorta. Besides, we further found that the drainage of periaortic LVs was decreased and the immune cell population in the TLN was changed in TAD. Then, lymphatic-deficient models, including genetic ablation and TLN removal, indicated that lymphatic deficiency exacerbated TAD. Furthermore, enhancing lymphangiogenesis with hVEGF-C156S treatment inhibited TAD depended on an intact lymphatic system. Mechanistically, single-cell RNA sequencing analysis showed that lymphatic endothelial cells (LECs) recruited immune cells by CXCL12-CXCR4 signalling in TAD. Importantly, blockade of CXCR4 by AMD3100 abolished the protective role of hVEGF-C156S in TAD, revealing that periaortic LVs protected against TAD progression via CXCL12-CXCR4 signalling. Finally, single-cell RNA sequencing analysis of human TAD tissue confirmed that LEC-induced immune cell recruitment played a key role in TAD.

Conclusion

Our findings demonstrated that the TLN and associated periaortic LVs form a functional lymphatic system, which drains the thoracic aorta and plays an inhibitory role in TAD progression, indicating that enhancing lymphatic function may represent a potential therapeutic strategy for treating TAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic VesselsAortic DissectionAortic Aneurysm, ThoracicLymphangiogenesisAorta, ThoracicEndothelial CellsLymph NodesAnimalsHumansDisease Models, AnimalReceptors, CXCR4MaleSignal TransductionMice, Inbred C57BLChemokine CXCL12FemaleCase-Control StudiesMiceInflammation MediatorsMiddle AgedDissection, Thoracic Aorta

Stichwörter der Autor:innen

Aortic dissectionCXCR4Draining lymph nodesLymphatic vesselsVEGF-C156S

Substanzen

Receptors, CXCR4Chemokine CXCL12CXCR4 protein, humanCXCR4 protein, mouseCXCL12 protein, humanInflammation Mediators

Autor:innen und Institutionen

  • Laboratory of Vascular Biology, Institute of Molecular Medicine, School of Future Technology, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, No. 5 Yiheyuan Road, Haidian District, Beiji…
  • Center for Stem Cell and Regenerative Medicine, Institute of Blood Transfusion, Chinese Academy of Medical Sciences/Peking Union Medical College, No. 76 Huacai Road, Chenghua District, Chengdu, Sichuan 610052, China.
  • Department of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China.
  • Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm 17177, Sweden.
  • Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.

ORCID-Profile: Yanjiani Xu, Fangyang Huang, Mao Chen

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • National Key research and Development Program of China

Zitieren

APA

Pei, Y., Lin, W., Zhang, T., Chu, X., Xu, H., Sun, Y., Xu, M., Xu, Y., Huang, F., Huang, D., Shi, L., Zhao, H., Li, M., Zhao, D., Zhang, H., Jiang, W., Chen, M., Luo, J., & Zhou, C. (2025). Periaortic lymphatic vessels protect against thoracic aortic dissection through mobilizing immune response. Cardiovascular Research, 121(16), 2594-2609. https://doi.org/10.1093/cvr/cvaf215

Vancouver

Pei Y, Lin W, Zhang T, Chu X, Xu H, Sun Y, et al. Periaortic lymphatic vessels protect against thoracic aortic dissection through mobilizing immune response. Cardiovascular Research. 2025;121(16):2594-2609. doi:10.1093/cvr/cvaf215

BibTeX
@article{Pei2025,
  author = {Pei, Yujun and Lin, Weirui and Zhang, Tao and Chu, Xiangyu and Xu, Han and Sun, Yizhe and Xu, Min and Xu, Yanjiani and Huang, Fangyang and Huang, Di and Shi, Liang and Zhao, Hu and Li, Mingzhao and Zhao, Dangfeng and Zhang, Hongjia and Jiang, Wenjian and Chen, Mao and Luo, Jincai and Zhou, Changping},
  title = {Periaortic lymphatic vessels protect against thoracic aortic dissection through mobilizing immune response},
  journal = {Cardiovascular Research},
  year = {2025},
  volume = {121},
  number = {16},
  pages = {2594--2609},
  doi = {10.1093/cvr/cvaf215}
}
Kostenlos starten →